Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cambau

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 5, 2016
Joint efforts urgently needed at times of emerging tuberculosis drug resistanceF Allerberger, E Cambau, C Lange
Revue Des Maladies Respiratoires|September 4, 2004
[What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Gene amplification tests]V Jarlier, E Cambau, W Sougakoff
Medecine Et Maladies Infectieuses|October 3, 2015
Update on the epidemiology, diagnosis, and treatment of leprosyF Reibel, E Cambau, A Aubry
FEMS Microbiology Letters|February 1, 1994
Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteriaE Cambau, W Sougakoff, V Jarlier
Antimicrobial Agents and Chemotherapy|August 4, 1998
Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteriaI Guillemin, V Jarlier, E Cambau
Annales De Chirurgie Plastique Et Esthetique|January 1, 1991
[Bacterial population on the site of loss of cutaneous substance. Its role on the success of skin graft]J M Kirsch, C Ventura, E Cambau
Antimicrobial Agents and Chemotherapy|December 31, 1998
Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosaH Mouneimné, J Robert, V Jarlier, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolonesV Revel, E Cambau, V Jarlier, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acidE Cambau, F Bordon, E Collatz, et al.
Presse Medicale (Paris, France : 1983)|April 5, 1997
[Generalized Mycobacterium avium complex infections in patients with HIV infection: a decreasing incidence]E Cambau, M Jouan, V Jarlier, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 5, 2016
Joint efforts urgently needed at times of emerging tuberculosis drug resistanceF Allerberger, E Cambau, C Lange
Revue Des Maladies Respiratoires|September 4, 2004
[What are the new diagnostic tools in tuberculosis? What is their role in disease management and what are their indications? Gene amplification tests]V Jarlier, E Cambau, W Sougakoff
Medecine Et Maladies Infectieuses|October 3, 2015
Update on the epidemiology, diagnosis, and treatment of leprosyF Reibel, E Cambau, A Aubry
FEMS Microbiology Letters|February 1, 1994
Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteriaE Cambau, W Sougakoff, V Jarlier
Antimicrobial Agents and Chemotherapy|August 4, 1998
Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteriaI Guillemin, V Jarlier, E Cambau
Annales De Chirurgie Plastique Et Esthetique|January 1, 1991
[Bacterial population on the site of loss of cutaneous substance. Its role on the success of skin graft]J M Kirsch, C Ventura, E Cambau
Antimicrobial Agents and Chemotherapy|December 31, 1998
Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosaH Mouneimné, J Robert, V Jarlier, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolonesV Revel, E Cambau, V Jarlier, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acidE Cambau, F Bordon, E Collatz, et al.
Presse Medicale (Paris, France : 1983)|April 5, 1997
[Generalized Mycobacterium avium complex infections in patients with HIV infection: a decreasing incidence]E Cambau, M Jouan, V Jarlier, et al.
Pageof 9